US 7557084
IL-18 specific polypeptides and therapeutic uses thereof
granted A61KA61K38/00
Quick answer
US patent 7557084 (IL-18 specific polypeptides and therapeutic uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K38/00